Karo Pharma applies the Swedish Code of Corporate Governance (“the Code”). This section of the website contains information and documents relating to corporate governance.
Comments are made in the appropriate section of the annual Corporate Governance Report for any deviations that the company has decided to make from the Code. The Corporate Governance Report is reviewed annually by the company’s auditor.
The highest decision-making body is the General Meeting of shareholders, where the shareholders exercise their influence in the company. Each share equates to one vote. The Annual General Meeting is held within six months of the end of the financial year. At the Annual General Meeting, the shareholders adopt resolutions regarding such matters as the election of the members of the Board of Directors and, where appropriate, the auditors, the appointment of the Nominating Committee and discharge from responsibility for the members of the Board of Directors and the CEO for the previous year. Resolutions are also adopted regarding the preparation of the financial statements, the allocation of profit, the fees for the Board of Directors and auditors and guidelines for the remuneration of the President and other senior executives.